Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
Author(s) -
Krzysztof Mrózek,
Guido Marcucci,
Deedra Nicolet,
Kati Maharry,
Heiko Becker,
Susan P. Whitman,
Klaus H. Metzeler,
Sebastian Schwind,
Yue-Zhong Wu,
Jessica Kohlschmidt,
Mark J. Pettenati,
Nyla A. Heerema,
AnneMarie W. Block,
Shivanand R. Patil,
Maria R. Baer,
Jonathan E. Kolitz,
Joseph O. Moore,
Andrew J. Carroll,
Richard M. Stone,
Richard A. Larson,
Clara D. Bloomfield
Publication year - 2012
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2012.43.4738
Subject(s) - medicine , cebpa , myeloid leukemia , adverse effect , npm1 , cytogenetics , leukemia , oncology , karyotype , mutation , gene , biochemistry , chemistry , chromosome
To evaluate the prognostic significance of the international European LeukemiaNet (ELN) guidelines for reporting genetic alterations in acute myeloid leukemia (AML).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom